WS
PHAS

Wedbush Securities’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Wedbush Securities’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,865
Closed -$49K – 1021
2020
Q3 		$49K Buy
13,865
+2,465
+22% +$8.71K ﹤0.01% 885
2020
Q2 		$52K Buy
+11,400
New +$52K ﹤0.01% 903